10.02.26 -- Can Virtual Biotechs Thrive Without Institutional Capital?

Are minor inconsistencies in room setup and technician technique quietly compromising your study data? Learn how closing small operational gaps can prevent major downstream risks.

Let's take a look at where continuous, real-time regulatory review can meaningfully speed drug development, and where it likely won't help much.

Upstream productivity gains and evolving antibody formats are raising the bar for chromatography polishing, making it a more consequential variable in downstream process design.

The biopharmaceutical industry faces growing downstream processing challenges in purifying complex biologics efficiently and at scale.

Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization. 

T3P is a versatile reagent for many kinds of functional group transformations. Review its advantages and recommendations for use.